Some notable examples targeting needs for muscle maintenance - the yogurt brand Oikos launched a cultured dairy drink with added whey protein and Vitamin D, and Nestls Vital Pursuit frozen meals are positioned for GLP-1 users with their portion control, added protein, and fiber
This can be done in conjunction with a consultation for surgical treatments or as a standalone procedure
CJC 1295 with DAC produces a blunted, continuous GH background rather than a physiologic pulse
CagriSema vs Comparators Feature Receptor targets CagriSema Amylin/calcitonin + GLP-1 Tirzepatide (Zepbound) GIP + GLP-1 Semaglutide alone (Wegovy) GLP-1 Cagrilintide alone Amylin/calcitonin (DACRA) Feature Dosing frequency CagriSema Once weekly Tirzepatide (Zepbound) Once weekly Semaglutide alone (Wegovy) Once weekly Cagrilintide alone Once weekly Feature Maintenance dose CagriSema 2.4 mg + 2.4 mg Tirzepatide (Zepbound) Up to 15 mg Semaglutide alone (Wegovy) 2.4 mg Cagrilintide alone 2.4 mg (in REDEFINE arms) Feature Headline weight loss CagriSema 20.4% at 68 wks (REDEFINE 1, treatment-policy) Tirzepatide (Zepbound) Up to 22.5% at 72 wks (SURMOUNT-1, 15 mg arm) Semaglutide alone (Wegovy) 14.9% at 68 wks (REDEFINE 1 reference arm) Cagrilintide alone 11.5% at 68 wks (REDEFINE 1 reference arm) Feature FDA status (June 2026) CagriSema NDA filed Dec 2025
Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights
READ HERE: #Semaglutide #GLP1 #AlcoholUseDisorder #AddictionMedicine #Obesity #ClinicalResearch #EvidenceBasedMedicine #MetabolicHealth #Medicine #HealthcareInnovation To view or add a comment, sign in More Relevant Posts It has been quite a busy few weeks with phase 3 data depression readouts from #psilocybin and #LSD